cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biomea Fusion Inc
4 own
6 watching
Current Price
$0
$0.53
(1.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,239.42M
52-Week High
52-Week High
43.69
52-Week Low
52-Week Low
6.04
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,239.42M
icon52-Week High43.69
icon52-Week Low6.04
iconAverage Volume0.07M
iconDividend Yield--
iconP/E Ratio--
What does the Biomea Fusion Inc do?
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective irreversible inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Read More
How much money does Biomea Fusion Inc make?
News & Events about Biomea Fusion Inc.
Globe Newswire
1month ago
BMF-500, a novel 3rd generation covalent inhibitor of fms-like tyrosine kinase 3 (FLT3), is the second investigational compound, discovered and developed by Biomeas FUSION System, to advance to the clinic.Phase I study (COVALENT-103) of BMF-500 will examine its safety and efficacy in patients with ...
Globe Newswire
1month ago
New clinical data from COVALENT-111 will be featured during the Late-Breaking Poster Presentations at the Scientific SessionsBiomea to hold an investor and KOL event during the Scientific Sessions REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea) (Nasdaq: BMEA), a...
Globe Newswire
1month ago
REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea or the Company) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined ...
Globe Newswire
2 months ago
REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and ...
Globe Newswire
2 months ago
REDWOOD CITY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (Biomea) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and ...
Frequently Asked Questions
Frequently Asked Questions
What is Biomea Fusion Inc share price today?
plus_minus_icon
Can Indians buy Biomea Fusion Inc shares?
plus_minus_icon
How can I buy Biomea Fusion Inc shares from India?
plus_minus_icon
Can Fractional shares of Biomea Fusion Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biomea Fusion Inc stocks?
plus_minus_icon
What is today’s traded volume of Biomea Fusion Inc?
plus_minus_icon
What is today’s market capitalisation of Biomea Fusion Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biomea Fusion Inc?
plus_minus_icon
What percentage is Biomea Fusion Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biomea Fusion Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.53
(1.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00